BCMA-CS1 Compound CAR (cCAR) T Cells for Relapsed/Refractory Multiple Myeloma
Clinical trial NCT04156269 · UNKNOWN
Trial details
- NCT number
- NCT04156269
- Sponsor
- iCell Gene Therapeutics
- Status
- UNKNOWN
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-08-31
- Primary completion
- 2021-09-01
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.